Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Lini Pandite

3PUBLICATIONS

12CO-AUTHORS

Infectious agentsMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jun 27, 2026

Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease.

|Apr 08, 2026

Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.

Yvette Drew, Lucy Gilbert, Alejandro Martinez Bueno

|Jan 12, 2025

First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer.

Nehal J Lakhani, Daphne Stewart, Debra L Richardson

Pageof 1

Frequent Collaborators

1 joint publications

Nehal J Lakhani

1 joint publications

Debra L Richardson

1 joint publications

Yvette Drew

1 joint publications

Ana Oaknin

1 joint publications

Victor Moreno

1 joint publications

Rebecca S Kristeleit

1 joint publications

Susana Banerjee

1 joint publications

Daniela Matei

1 joint publications

Elisa Galvez

1 joint publications

Anne Y Lai

Frequent Collaborators

1 joint publications

Nehal J Lakhani

1 joint publications

Debra L Richardson

1 joint publications

Yvette Drew

1 joint publications

Ana Oaknin